James Fossetta

1.3k total citations
25 papers, 935 citations indexed

About

James Fossetta is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, James Fossetta has authored 25 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Organic Chemistry. Recurrent topics in James Fossetta's work include Immune Response and Inflammation (6 papers), Synthesis and biological activity (5 papers) and Quinazolinone synthesis and applications (5 papers). James Fossetta is often cited by papers focused on Immune Response and Inflammation (6 papers), Synthesis and biological activity (5 papers) and Quinazolinone synthesis and applications (5 papers). James Fossetta collaborates with scholars based in United States and United Kingdom. James Fossetta's co-authors include Daniel Lundell, Charles A. Lunn, Satwant K. Narula, Thierry Fischmann, Alan Hruza, Paul Reichert, Andrew Prongay, Xuedong Fan, Gregory Deno and R. William Hipkin and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

James Fossetta

25 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Fossetta United States 15 364 294 219 176 170 25 935
Alan Hruza United States 15 650 1.8× 266 0.9× 169 0.8× 212 1.2× 190 1.1× 23 1.2k
Vered Klinghofer United States 21 580 1.6× 288 1.0× 99 0.5× 372 2.1× 338 2.0× 27 1.3k
Tomohiro Kawamoto Japan 24 1.1k 3.1× 138 0.5× 243 1.1× 473 2.7× 301 1.8× 61 1.9k
Wayne L. Cody United States 23 828 2.3× 320 1.1× 38 0.2× 420 2.4× 93 0.5× 71 1.5k
Khalilah G. Reddie United States 10 713 2.0× 94 0.3× 79 0.4× 196 1.1× 74 0.4× 11 1.2k
A.V. Wallace United Kingdom 15 326 0.9× 198 0.7× 45 0.2× 165 0.9× 41 0.2× 20 706
Veena Somasundaram United States 19 348 1.0× 142 0.5× 155 0.7× 88 0.5× 184 1.1× 26 889
Stefania Girotto Italy 20 585 1.6× 204 0.7× 50 0.2× 106 0.6× 118 0.7× 41 1.4k
JOHN H. MUSSER United States 17 446 1.2× 170 0.6× 107 0.5× 448 2.5× 62 0.4× 55 1.1k
Denis V. Titov United States 17 1.3k 3.5× 129 0.4× 67 0.3× 186 1.1× 96 0.6× 27 1.7k

Countries citing papers authored by James Fossetta

Since Specialization
Citations

This map shows the geographic impact of James Fossetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Fossetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Fossetta more than expected).

Fields of papers citing papers by James Fossetta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Fossetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Fossetta. The network helps show where James Fossetta may publish in the future.

Co-authorship network of co-authors of James Fossetta

This figure shows the co-authorship network connecting the top 25 collaborators of James Fossetta. A scholar is included among the top collaborators of James Fossetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Fossetta. James Fossetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muntean, Brian S., Dipak N. Patil, Franck Madoux, et al.. (2018). A High-Throughput Time-Resolved Fluorescence Energy Transfer Assay to Screen for Modulators of RGS7/Gβ5/R7BP Complex. Assay and Drug Development Technologies. 16(3). 150–161. 3 indexed citations
2.
Seganish, W. Michael, William T. McElroy, Rui Zhang, et al.. (2016). Efforts towards the optimization of a bi-aryl class of potent IRAK4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(17). 4250–4255. 13 indexed citations
3.
Seganish, W. Michael, William T. McElroy, R. Jason Herr, et al.. (2015). Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4. Bioorganic & Medicinal Chemistry Letters. 25(16). 3203–3207. 7 indexed citations
4.
Xiao, Dong, Xiaohong Zhu, Sylvia J. Degrado, et al.. (2014). Discovery of a novel series of potent MK2 non-ATP competitive inhibitors using 1,2-substituted azoles as cis-amide isosteres. Bioorganic & Medicinal Chemistry Letters. 24(15). 3609–3613. 14 indexed citations
5.
Xiao, Dong, Anandan Palani, Xianhai Huang, et al.. (2013). Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(11). 3262–3266. 21 indexed citations
6.
Huang, Xianhai, Xiaohong Zhu, Xiaohong Chen, et al.. (2011). A three-step protocol for lead optimization: Quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(1). 65–70. 18 indexed citations
7.
Xiao, Dong, Xianhai Huang, Wei Zhou, et al.. (2011). Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(2). 1068–1072. 53 indexed citations
8.
Taveras, Arthur G., Younong Yu, Junying Zheng, et al.. (2009). 3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(5). 1434–1437. 8 indexed citations
9.
Taveras, Arthur G., Younong Yu, Junying Zheng, et al.. (2007). 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(1). 228–231. 16 indexed citations
10.
Gonsiorek, Waldemar, Xuedong Fan, David Hesk, et al.. (2007). Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist. Journal of Pharmacology and Experimental Therapeutics. 322(2). 477–485. 101 indexed citations
11.
Gonsiorek, Waldemar, David Hesk, Shu‐Cheng Chen, et al.. (2006). Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336. Journal of Biological Chemistry. 281(38). 28143–28151. 20 indexed citations
12.
Fossetta, James, Gregory Deno, Waldemar Gonsiorek, et al.. (2004). Pharmacological characterization of human S1P4 using a novel radioligand, [4,5‐3H]‐dihydrosphingosine‐1‐phosphate. British Journal of Pharmacology. 142(5). 851–860. 9 indexed citations
13.
Fossetta, James, James Jackson, Gregory Deno, et al.. (2003). Pharmacological Analysis of Calcium Responses Mediated by the Human A3 Adenosine Receptor in Monocyte-Derived Dendritic Cells and Recombinant Cells. Molecular Pharmacology. 63(2). 342–350. 51 indexed citations
14.
Windsor, William T., Leigh J. Walter, Rosalinda Syto, et al.. (1996). Purification and crystallization of a complex between human interferon γ receptor (extracellular domain) and human interferon γ. Proteins Structure Function and Bioinformatics. 26(1). 108–114. 7 indexed citations
15.
Fossetta, James, et al.. (1996). Expression of human inducible nitric oxide synthase in Escherichia coli. FEBS Letters. 379(2). 135–138. 30 indexed citations
16.
Lunn, Charles A., James Fossetta, David C. Dalgarno, et al.. (1992). A point mutation of human interferon γ abolishes receptor recognition. Protein Engineering Design and Selection. 5(3). 253–257. 20 indexed citations
17.
Lunn, Charles A., et al.. (1992). A point mutation that decreases the thermal stability of human interferon γ. Protein Engineering Design and Selection. 5(3). 249–252. 6 indexed citations
18.
Lundell, Daniel, Charles A. Lunn, David C. Dalgarno, et al.. (1991). The carboxyl-terminal region of human interferon γ is important for biological activity: mutagenic and NMR analysis. Protein Engineering Design and Selection. 4(3). 335–341. 64 indexed citations
19.
Lundell, D J, Charles A. Lunn, Robert S. Greenberg, et al.. (1990). Exploiting the cell membrane for the production of heterologous proteins in Escherichia coli. Biotechnology and Applied Biochemistry. 12(5). 567–578. 3 indexed citations
20.
Lundell, Daniel, Robert S. Greenberg, James Fossetta, et al.. (1990). Cytoplasmic and periplasmic expression of a highly basic protein, human interleukin 4, inEscherichia coli. Journal of Industrial Microbiology & Biotechnology. 5(4). 215–227. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026